Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy Volunteers
NCT01777685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2013-01-29
Summary
The present study was adopted to evaluate the pharmacokinetics of sulpiride after oral administration.
Conditions
- Healthy
Interventions
- DRUG
-
Sulpiride
Sponsors & Collaborators
-
Damanhour University
lead OTHER
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- Egypt
Study Locations
More Related Trials
-
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
NCT07076459 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
NCT05814926 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers
NCT06699628 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects
NCT02667639 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects
NCT04326881 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets
NCT01083290 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Sudapyridine(WX-081)in Healthy Chinese Subjects
NCT06701110 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function
NCT05735951 ·Status: COMPLETED ·Phase: PHASE1
-
Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration
NCT02350725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neostigmine Versus Sugammadex on Renal Functions
NCT06081738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment
NCT03160014 ·Status: UNKNOWN ·Phase: PHASE1
-
Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function
NCT06961643 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
NCT01129661 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
NCT01796938 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
NCT02047656 ·Status: TERMINATED ·Phase: PHASE1
-
Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers
NCT01176851 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
NCT01074710 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
NCT03565861 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment
NCT04293029 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects
NCT01877629 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04536961 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003)
NCT01263314 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment
NCT06674915 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment
NCT03289234 ·Status: COMPLETED ·Phase: PHASE1